J&J Reports Positive Phase 3 MajesTEC-9 Results for Tecvayli in Earlier Multiple Myeloma
Tecvayli; J&J; Phase 3; MajesTEC-9; multiple myeloma; PFS; OS
Antengene Presents at JPM: Strong Clinical Data Update and Strategic Focus on Next-Generation ADCs and TCEs
Antengene; JPM Conference; ATG-022; ADCs; TCEs; AnTenGager; ATG-125; ATG-207
FDA Delays Reviews for Eli Lilly, Sanofi, and Others in New Priority Voucher Program Due to Safety and Efficacy Concerns
FDA delays; Eli Lilly; Sanofi; voucher program; orforglipron; Tzield; safety concerns; efficacy issues
Fosun Pharma’s Global Ambitions: Innovation-Driven Expansion in 2025
Fosun Pharma; global expansion; innovative drugs; 2025 results; licensing deals
Novo Nordisk Foundation Commits Over $850M to Danish Life Science Incubator BII Over Next Decade
Novo Nordisk Foundation; BII; life science incubator; $850M; biotech startups; Denmark
Caldera Therapeutics Launches with $112.5M Funding for China-Licensed IBD Bispecific Antibody
Caldera Therapeutics; IBD; bispecific antibody; $112.5M funding; Qyuns Therapeutics; CLD-423
JPM26 Day 3: Sanofi CEO on RSV Scrutiny and Regeneron Dupixent Defense
JPM26; Sanofi; RSV; Beyfortus; Paul Hudson; FDA; vaccines; Dupixent; Regeneron
AI Advances in High-Throughput Genomics: Sequence-Based Screening and Rapid Genome Analysis
sequence-based AI; whole genome screening; small molecule candidates; antibody candidates; genomics AI; Virtual Geneticist; SBX sequencing
Cityblock Health Appoints New CTO and Tech-Focused Board Members to Accelerate AI-Driven Care
Cityblock Health; CTO; Alberto Lopez Toledo; board members; AI; Medicaid
Insilico Medicine Integrates Nach01 Foundation Model with Microsoft Discovery for AI-Native Drug Discovery
Insilico Medicine; Nach01; Microsoft Discovery; AI drug discovery; Azure; foundation model